Microalbuminuria, the urinary albumin excretion of more than 20 micrograms per minute or more than 30 mg in 24 hours. The detection of urine microalbumin is the early detection of kidney disease is the most sensitive and reliable diagnostic indicators. Urinary albumin values, combined with the incidence, symptoms and medical history statement to more accurately diagnose the illness. Determine the condition to enter that stage of fibrosis. Therefore, regular testing of urinary albumin (U-MA), ordinary people should be once a year, it increased patients should be tested once every three months. Thus, for the prevention and early treatment of kidney disease have played a positive role.
Urinary albumin to assess the degree of kidney damage: when found in urine albumin 20mg/L-200mg/L range, urine routine urine protein is negative (-) or (+ -), belongs to the albumin urine, this time shows have been kidney damage, if the patient after standard repair of renal units, reversing fibrosis treatment, they can still complete repair of the glomerular elimination of proteinuria. When the albumin in the urine of more than 200mg / L, the urine test urine protein-positive (+) - (+ +), should be wary, then prove that the body has been a large number of albumin leakage may be low protein in blood disease, kidney disease development from the irreversible only one step away, if you do not timely medical treatment, will enter uremia.
Therefore, regular testing of urinary albumin (U-MA), ordinary people should be once a year, it increased patients should be tested once every three months. Thus, for the prevention and early treatment of kidney disease have played a positive role.
Micro-based medicine penetration therapy is a treatment for chronic kidney summed up the nation's largest kidney specialist hospital in kidney disease hospital in the 20 years of long-term clinical practice effective innovative therapies, micro-based medicine penetrate therapy kidney disease hospital patents, in other places there is no other hospitals. And then with the effective penetrant and penetration, topical approach, the effective drug penetration to the site of renal lesions, to achieve the purpose of effective treatment of kidney disease. This innovative therapy, the elimination of the side effects of oral medication, but also to achieve the purpose of drug ingredients enter the effective lesions. Moreover, this innovative therapies, clinical practice has proved both effective and convenient. The therapy has become a major feature of the kidney disease hospital core support treatment technology, living in the core position of Kidney hospital for treatment.
